atogepant
Treatment for Cluster Headache
Atogepant is a potent, orally bioavailable calcitonin gene-related peptide (CGRP) receptor antagonist that blocks CGRP-mediated vasodilation and neurogenic inflammation. In cluster headache treatment, it works by inhibiting the CGRP pathway, thereby reducing the frequency and severity of headache attacks by preventing neuropeptide-induced pain signaling and vascular changes.
1279
REPORTED SIDE EFFECTS